Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a co-packaged prescription kit used for the eradication of *Helicobacter pylori* infection. It typically contains a combination of Esomeprazole (PPI), Amoxicillin (penicillin antibiotic), and Clarithromycin (macrolide antibiotic).
## Primary Indications
Treatment of *H. pylori* infection to reduce the risk of duodenal ulcer recurrence.
## Adult Dosing
Standard regimen (typically 10-14 days):
* **Esomeprazole:** 40 mg orally twice daily.
* **Amoxicillin:** 1000 mg orally twice daily.
* **Clarithromycin:** 500 mg orally twice daily.
## Pediatric Dosing
**Safety and efficacy not established.** Use in pediatric patients is generally not recommended due to the standard inclusion of clarithromycin and specific sensitivities related to PPI usage.
## Dose Adjustments
* **Renal Impairment:** Amoxicillin and Clarithromycin require dose adjustment in severe renal impairment (CrCl <30 mL/min).
* **Hepatic Impairment:** Use caution with Clarithromycin in patients with hepatic impairment; dose adjustments may be necessary.
* **Elderly:** Use with caution; monitor for increased sensitivity to adverse effects.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any macrolide antibiotic.
* Concomitant use with drugs dependent on CYP3A4 metabolism for clearance (e.g., pimozide, cisapride, ergot alkaloids) due to high risk of QT prolongation or toxicity.
* History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use.
## Adverse Effects
* **Common:** Diarrhea, dysgeusia (metallic taste), nausea, abdominal pain, headache, and dizziness.
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), severe hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome), QT interval prolongation, and acute interstitial nephritis.
## Key Drug Interactions
* **CYP3A4 Inhibitors/Substrates:** Clarithromycin is a potent inhibitor; can significantly increase serum levels of statins (atorvastatin, simvastatin), colchicine, and anticoagulants (warfarin).
* **pH-Dependent Drugs:** Esomeprazole decreases the absorption of drugs requiring acidic gastric pH (e.g., atazanavir, ketoconazole, iron salts).
* **Methotrexate:** PPIs may increase serum methotrexate levels.
## Monitoring
* Monitor for signs of *C. difficile* (persistent diarrhea).
* Monitor INR if on concurrent warfarin.
* Periodic monitoring of renal and hepatic function during extended courses.
* Document resolution of *H. pylori* symptoms; confirm eradication via urea breath test or fecal antigen test 4 weeks after therapy completion.
## Clinical Pearls
* **Adherence is critical:** Completing the full 10-14 day course is essential to prevent antibiotic resistance.
* **Clarithromycin resistance:** Prevalence of resistance is increasing; local susceptibility patterns should guide therapy choice.
* **Administration:** Esomeprazole should be taken at least 60 minutes before meals.
* **Uncertainty:** Dosing protocols vary significantly by geographic region and local resistance guidelines. Always consult current institutional antibiograms.
***
**Educational Disclaimer:** This information is for educational purposes and does not constitute medical advice. Verify all dosages, contraindications, and drug interactions against the most current FDA-approved labeling or local clinical prescribing guidelines before clinical use.
